TITLE

Direct-to-consumer advertising: end the compromise

AUTHOR(S)
Hébert, Paul C.
PUB. DATE
July 2008
SOURCE
CMAJ: Canadian Medical Association Journal;7/15/2008, Vol. 179 Issue 2, p119
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The author reflects on the direct-to consumer advertising for drugs and medical devices despite its prohibition by federal regulations. In Canada, direct-to-consumer advertising is prohibited, but Health Canada allows deep advertisement of either the product or the medical condition. American companies operating in Canada had the immunity and abide American rules which was being regulated by the U.S. Food and Drug Administration (FDA).
ACCESSION #
32981149

 

Related Articles

  • DTC device ads have merit. Hempstead, Susan // Medical Marketing & Media;Jan2006, Vol. 41 Issue 1, p93 

    The article reports that the U.S. Food and Drug Administration (FDA) has sponsored a series of public meetings to solicit information and views about direct-to-consumer (DTC) promotion of prescription drug products through print, broadcast or other types of media. DTC media-product...

  • Marketers Ante Up for Ad Reviews. J. W. // Pharmaceutical Executive;Jan2008, Vol. 28 Issue 1, p20 

    The article reports that the new fee-for-direct to consumer (DTC) advertisement (ad) review program of the U.S. Food and Drug Administration (FDA) has received several commitments from marketers by November 2007 sign-up rolling. According to the author, 31 marketing entities have filed requests...

  • Turf War Escalates Over Big Pharma Marketing. Edwards, Jim // Brandweek;11/7/2005, Vol. 46 Issue 40, p6 

    This article focuses on the efforts of the U.S. Food and Drug Administration to review policies on direct-to-consumer (DTC) drug advertising as of November 2005. The policies were brought about by the pleas of parties wanting to ban DTC advertising. While no marketer proposed a total advertising...

  • NOTHING BUT BLUE SKIES? Thomaselli, Rich // Advertising Age;10/2/2006, Vol. 77 Issue 40, p3 

    The article focuses on the status of direct-to-consumer (DTC) television advertising from drug companies in the U.S. Since the Food and Drug Administration's decision to relax the guidelines regarding DTC advertisements, the category has emerged from a dawdling $12 million business to a $4.1...

  • FDA close to easing limits on Rx TV ads. Wilke, Michael // Advertising Age;6/30/1997, Vol. 68 Issue 26, p1 

    The article reports on a United States Food and Drug Administration (FDA) official's claim that the agency is considering allowing marketers to name both a prescription drug and the ailment it treats in consumer advertising. Such a change in the FDA guidelines for advertising could bring an...

  • Marketers Lobby FDA. J. W. // Pharmaceutical Executive;May2006, Vol. 26 Issue 5, p28 

    The article reports that the advertising and public relations industry groups have petition the U.S. Food and Drug Administration (FDA) to revise its rules governing direct-to-consumer (DTC) advertising. Despite the possibility that the FDA will not revise its rules, the request may focus...

  • Evaluating the Welfare Effects of Drug Advertising. Bardford, W. David; Kleit, Andrew N. // Regulation;Spring2006, Vol. 29 Issue 1, p58 

    Discusses the health benefits of drug advertisements to consumers. Changes implemented by the U.S. Food and Drug Administration on the rules for the broadcast of direct-to-consumer advertising (DCA) of prescription drugs in August 1997; Effect of DCA on physicians and patients; Evaluative...

  • A critical look at prescription drug direct-to-consumer advertising.  // Formulary;Feb2007, Vol. 42 Issue 2, p125 

    The article discusses several issues surrounding the direct-to-consumer advertising (DTCA) of prescription drugs since its approval in 1997 by the U.S. Food and Drug Administration (FDA). There has been an increasing debate regarding the methods used by advertisers in influencing the consumers...

  • Abrams is 'pleased' with PhRMA'sDTC guidelines. Dickinson, James G. // Medical Marketing & Media;Nov2005, Vol. 40 Issue 11, p14 

    Comments on the reaction of the Food and Drug Administration to Pharmaceutical Research and Manufacturers of America's direct-to-consumer (DTC) pharmaceutical advertising guiding principles in the U.S. Statement of Division of Drug Marketing, Advertising and Communications director Tom Abrams on...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics